Hide metadata

dc.date.accessioned2020-06-23T17:49:24Z
dc.date.available2020-06-23T17:49:24Z
dc.date.created2020-01-08T08:36:50Z
dc.date.issued2019
dc.identifier.citationGoel, Gautam Tye-Din, Jason A. Qiao, Shuo Wang Russell, Amy K. Mayassi, Toufic Ciszewski, Cezary Sarna, Vikas Kumar Wang, Suyue Goldstein, Kaela E. Dzuris, John L. Williams, Leslie J. Xavier, Ramnik J. Lundin, Knut Erik Aslaksen Jabri, Bana Sollid, Ludvig Magne Anderson, Robert P. . Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease. Science Advances. 2019, 5:eaaw7756(8), 1-15
dc.identifier.urihttp://hdl.handle.net/10852/77138
dc.description.abstractCeliac disease (CeD), caused by immune reactions to cereal gluten, is treated with gluten -elimination diets. Within hours of gluten exposure, either perorally or extraorally by intradermal injection, treated patients experience gastrointestinal symptoms. To test whether gluten exposure leads to systemic cytokine production time -related to symptoms, series of multiplex cytokine measurements were obtained in CeD patients after gluten challenge. Peptide injection elevated at least 15 plasma cytokines, with IL-2, IL-8, and IL-10 being most prominent (fold-change increase at 4 hours of 272, 11, and 1.2, respectively). IL-2 and IL-8 were the only cytokines elevated at 2 hours, preceding onset of symptoms. After gluten ingestion, IL-2 was the earliest and most prominent cytokine (15-fold change at 4 hours). Supported by studies of patient-derived gluten-specific T cell clones and primary lymphocytes, our observations indicate that gluten-specific CD4+ T cells are rapidly reactivated by antigen -exposure likely causing CeD-associated gastrointestinal symptoms.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleCytokine release and gastrointestinal symptoms after gluten challenge in celiac disease
dc.typeJournal article
dc.creator.authorGoel, Gautam
dc.creator.authorTye-Din, Jason A.
dc.creator.authorQiao, Shuo Wang
dc.creator.authorRussell, Amy K.
dc.creator.authorMayassi, Toufic
dc.creator.authorCiszewski, Cezary
dc.creator.authorSarna, Vikas Kumar
dc.creator.authorWang, Suyue
dc.creator.authorGoldstein, Kaela E.
dc.creator.authorDzuris, John L.
dc.creator.authorWilliams, Leslie J.
dc.creator.authorXavier, Ramnik J.
dc.creator.authorLundin, Knut Erik Aslaksen
dc.creator.authorJabri, Bana
dc.creator.authorSollid, Ludvig Magne
dc.creator.authorAnderson, Robert P.
cristin.unitcode185,53,18,12
cristin.unitnameAvdeling for immunologi og transfusjonsmedisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.fulltextpostprint
cristin.qualitycode1
dc.identifier.cristin1768158
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Science Advances&rft.volume=5:eaaw7756&rft.spage=1&rft.date=2019
dc.identifier.jtitleScience Advances
dc.identifier.volume5
dc.identifier.issue8
dc.identifier.doihttps://doi.org/10.1126/sciadv.aaw7756
dc.identifier.urnURN:NBN:no-80246
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2375-2548
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/77138/2/eaaw7756.full.pdf
dc.type.versionPublishedVersion
cristin.articleideaaw7756


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International